Covid-19
Conditions
Interventions
Control group (n= 80): each patient will receive one non-transparent bottle, containing 28 non-transparent capsules. The capsules will contain standard placebo formulation, consisting of 0.5% magnesiu
Sponsors
Universidade do Sul de Santa Catarina
Universidade do Sul de Santa Catarina
Eligibility
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Patients over 18 years of age; clinical suspicion of Covid-19; oxygen saturation between 93% and 97%; at least one more symptom according to the Ministry of Health criteria including tiredness or shortness of breath; fever and chills reported; cough and loss of smell or taste; positive result for the D-dimer test
Exclusion criteria
Exclusion criteria: Patients with active infectious diseases; immunosuppressive diseases or active cancer; pregnant or lactating women; known renal failure; current use of anticoagulants; contraindication to the use of Edoxaban or Moxifloxacin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| frequency of individuals who required hospitalization after starting treatment (in %) | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected | — |
Countries
Brazil
Contacts
Public ContactAnna Piovezan
Outcome results
None listed